
RSUs vs. Stock Options: A Life Sciences Founder’s Guide
The equity compensation strategy that launched your biotech company in 2024 requires careful re-evaluation in 2026. Two years ago, your

The equity compensation strategy that launched your biotech company in 2024 requires careful re-evaluation in 2026. Two years ago, your

Building a tech or biotech startup requires assembling a world-class team. To attract top-tier engineers, clinical scientists, and seasoned executives,

Receiving restricted stock in your own startup is an exciting milestone for any founder. However, when that equity grant is

Summary for Founders Use stock options to conserve cash and retain talent Set the exercise price at fair market value

Summary for Founders: A general counsel (“GC”) helps you prevent early legal mistakes that become expensive during financing, hiring and

Summary for Founders: Lock down the grant date before you promise equity so your strike price lines up with

Summary for Founders Vesting acceleration decides what happens to your unvested equity when the company is sold Single-trigger acceleration

How to Protect Your Business From These 6 Startup Contract Risks As a startup founder, you know that written contracts

Build a Legal Foundation That Supports Long-Term Growth A promising idea might open doors, but it takes more than a

Strengthen Your Startup’s Legal Framework Before Success Tests It Many early-stage startup teams move fast, fueled by trust, optimism and

The Intensifying Cybersecurity Landscape: Protecting Your Most Valuable Asset “Data is the new oil,” a phrase coined by big data

How Crowley Law Can Help You Navigating the complicated legal landscape of startup equity can be extremely challenging. At Crowley

The Latest NVCA Legal Document Updates for 2025 The National Venture Capital Association (NVCA), the leading voice of the U.S.

Understanding the Risks of Federal Debt for Small Businesses The story of the “tar baby” serves as a perfect warning

Federal Court Declares Corporate Transparency Act Unconstitutional Big news on the legal front! The U.S. District Court for Northern Alabama has just

Why March‑In Rights Matter And Who’s at Risk If your patent was developed using federal funding, even partially, the U.S.

What Is the Corporate Transparency Act? Small privately-held companies will have new compliance burdens starting in the new year. The

FinCEN ID: Your Guide To Crucial CTA Compliance A new reporting requirement started on January 1, 2024. This change is
Over the years, I’ve seen a constant tension between capital market entrepreneurs and the regulators who try to set up
A New Era for Digital Assets in Traditional Finance Technology can be exciting – sometimes TOO exciting! In the ever-evolving

What Clean Tech Founders Need to Know Before Applying for the NJ R&D Voucher New Jersey is aggressively funding clean

For businesses located outside the United States, expanding your business focus to the USA is a bold choice towards growth

Why Non-Compete Agreements Are Now High-Risk Post-employment non-compete agreements, long a standard fixture in many employment contracts, are now facing

The Binding Power of the Click: Pacta Sunt Servanda (Agreements Must Be Kept) Pacta sunt servanda (Latin Maxim: Agreements must

The MedTech Funding Shift in 2025 Investment in medical technology startups has historically been a major engine of healthcare innovation.